New coding guidance: CCI 22.1 contains code pairs for drug screens, large retroactive deletion
Use caution when you attempt to report a drug screen with another lab service such as a pathology consult. And don’t assume that the edits for the new codes mirror those you had for high-complexity drug screen services in the past.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.